Coronavirus Watch: Moderna receives full FDA approval

Moderna's COVID-19 vaccine has received full approval from the U.S. Food and Drug Administration, the company announced Monday.

The decision comes more than a year after the vaccine was first granted "emergency use authorization" by the FDA. Moderna's is the second vaccine to receive full approval from the agency after Pfizer's vaccine received full approval for those 16 and up in August.

Moderna's approval is for individuals 18 and older in the two-dose primary series for vaccination. The booster dose is available under emergency use authorization.

It's Monday, and this is Coronavirus Watch from the Paste BN Network. Here's more news to know to start off your week:

• Beijing 2022 organizers reported 71 new cases over the weekend, bringing the total to almost 250 cases linked to the Winter Olympics as the opening ceremony nears.
• Spotify will add advisories to podcasts discussing COVID-19 after artists Neil Young and Joni Mitchell asked their music be removed from the streaming platform over the spread of vaccine misinformation.
• A Department of Homeland Security vaccine mandate, which took effect Jan. 22, is expected to severely restrict the travel of thousands of H-2A seasonal guest workers this year.
• Police in Canada said Sunday that they had launched several criminal investigations in relation to the "desecration" of the country's National War Memorial after thousands of demonstrators gathered to protest vaccine mandates and COVID restrictions.

See our COVID-19 resource guide here. See total reported cases and deaths here. On vaccinations: About 75% of people in the U.S. have received at least one vaccine shot, and about 64% are fully vaccinated, according to the CDC.

– Cady Stanton, Paste BN digital editor fellow, @cady_stanton